Share Doctor UK

Share Doctor UK Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Share Doctor UK, Financial service, GB

Tower Bridge Rd, London, SE1 3UN, London.

Wednesdays  SHARE MUSING, a hopefully weekly post on this wonderous site, if it is welcomeWhy do people invest in the st...
24/09/2024

Wednesdays SHARE MUSING, a hopefully weekly post on this wonderous site, if it is welcome
Why do people invest in the stock market?
About a fifth of Americans, owned shares 70 years ago, so its hardly a new concept, the percentage of owners is very country specific, however.
23% of British people as of 2024 own shares.
Over half of Australians, nearly 10 million, own shares.
The concept is that you own a small part of a company, you have a "share" of the company. The company must be public, I would love to own shares in Aldi, but it is a private company, so I can't.
Over time the stockmarket is the biggest wealth winner in investing, even a passive investor, someone, who buys a bundle of 15 companies & forgets they bought them should see 10% returns over 50 years. The compounding effect of long term investing are staggering & a great way of protecting yourself against inflation.
Real house prices in the UK (real means adjusted for inflation), have gone from 100K in 1975 to 261K this year, shockingly low to many Australians.
The stockmarket has gone from the playground of the rich to accessible to teenagers on mobile phones, even $1,000 is enough to get you started, there is no stamp duty, or land tax associated with share ownership & OZ is one of only 3 countries in the world to offer "franking credits' (probably worthy of it's own post).
The most important thing is to get started, try & get up to 30% of your after tax income into the stockmarket, even if you're not a stock picker at the start, there's &
Thats what I'll be telling my kids when they hit 18.

31/07/2024

LSE

What's it worth?

An expanding industry free of disruption should support annual revenue growth of 6-8%, aided by small acquisitions. This considers management's North American growth ambitions a bonus. We expect only modest improvements there.

Profits should grow faster as the benefits of greater route density, technology, and synergies fall to the bottom line. Overall, low- to mid-double-digit earnings growth seems achievable, with returns expected to follow earnings. By 2030, that would have the share price approaching 900p.

The scenario does come with risks, however. Terminix could be a perpetual fixer-upper, soaking up management's time to the detriment of the group's other businesses. Another large deal would be a fatal blow to our investment case given the trouble integrating this one.

Debt is another worry. At around 2.6 times EBITDA, it's higher than we'd like. Any further operational hiccups could exacerbate the issue and force management into a corner. However, the covenant-free structure, fixed low rates, and staggered maturities until 2032 partly offset our concerns. Our higher risk rating and modest recommended position size reflect these challenges.

Rentokil enjoys a leadership position in an industry that seldom changes. Large public companies are rarely available at discounts to their mum-and-dad rivals, as is the case here.

Available for 17 times 2024 earnings, Terminix's integration problems provide an attractive entry point for those willing to give management time. Below 465p, Rentokil is a BUY.

When I see anonymous posters on financial forums asking poorer people what to do with their cash....
16/07/2024

When I see anonymous posters on financial forums asking poorer people what to do with their cash....

 Penthouse said, sell at six.
10/07/2024


Penthouse said, sell at six.

Address

GB Tower Bridge Rd, London, SE1 3UN
London
SE1 3UN

Website

Alerts

Be the first to know and let us send you an email when Share Doctor UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share